Black Rock Inc. Alx Oncology Holdings Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,221,561 shares of ALXO stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,221,561

Previous 2,235,093 0.61%

Holding current value

$13.4 Million

Previous $33.3 Million 25.57%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$10.95 - $16.79 $148,175 - $227,202	-13,532 Reduced 0.61%	2,221,561 $24.8 Million
Q4 2023 Feb 13, 2024	BUY	$4.81 - $15.38 $1.89 Million - $6.03 Million	392,074 Added 21.27%	2,235,093 $33.3 Million
Q3 2023 Nov 13, 2023	BUY	$4.19 - $7.35 $227,345 - $398,803	54,259 Added 3.03%	1,843,019 $8.85 Million
Q2 2023 Aug 11, 2023	BUY	$4.37 - $9.56 $524,994 - $1.15 Million	120,136 Added 7.2%	1,788,760 $13.4 Million
Q1 2023 May 12, 2023	SELL	$4.52 - $11.71 $146,728 - $380,130	-32,462 Reduced 1.91%	1,668,624 $7.54 Million

Q4 2022 Feb 13, 2023	BUY	$9.51 - $12.95 $291,804 - $397,357	30,684 Added 1.84%	1,701,086 $19.2 Million
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $66,827 - $122,936	8,120 Added 0.49%	1,670,402 $16 Million
Q2 2022 Aug 12, 2022	BUY	$5.89 - $19.46 $1.81 Million - $5.97 Million	306,804 Added 22.63%	1,662,282 $13.4 Million
Q1 2022 May 12, 2022	BUY	$13.65 - $22.06 $203,480 - $328,848	14,907 Added 1.11%	1,355,478 $22.9 Million
Q4 2021 Feb 10, 2022	SELL	$21.49 - $74.4 $562,823 - $1.95 Million	-26,190 Reduced 1.92%	1,340,571 $28.8 Million
Q3 2021 Nov 09, 2021	BUY	$52.51 - $80.91 $6.01 Million - $9.26 Million	114,456 Added 9.14%	1,366,761 $101 Million
Q2 2021 Aug 11, 2021	BUY	$52.2 - $75.23 $65.4 Million - $94.2 Million	1,252,305 New	1,252,305 $68.5 Million

Others Institutions Holding ALXO

# of Institutions

115

Shares Held

38.4M

Call Options Held

132K

Put Options Held

19.7K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $246M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account